Global Monkeypox Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Monkeypox Vaccine market size was valued at US$ 7.6 million in 2024 and is forecast to a readjusted size of USD 10.9 million by 2031 with a CAGR of 5.5% during review period.
Monkeypox is a viral zoonosis (a virus transmitted to humans from animals) with symptoms very similar to those seen in the past in smallpox patients, although it is clinically less severe. With the eradication of smallpox in 1980 and subsequent cessation of smallpox vaccination, monkeypox has emerged as the most important orthopoxvirus for public health. Monkeypox primarily occurs in Central and West Africa, often in proximity to tropical rainforests and has been increasingly appearing in urban areas. Animal hosts include a range of rodents and non-human primates.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Monkeypox Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Monkeypox Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Monkeypox Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Monkeypox Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Monkeypox Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Monkeypox Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Monkeypox Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bavarian Nordic inks, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Monkeypox Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Monkeypox Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Monkeypox Vaccine, with price, sales quantity, revenue, and global market share of Monkeypox Vaccine from 2020 to 2025.
Chapter 3, the Monkeypox Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Monkeypox Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Monkeypox Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Monkeypox Vaccine.
Chapter 14 and 15, to describe Monkeypox Vaccine sales channel, distributors, customers, research findings and conclusion.
Monkeypox is a viral zoonosis (a virus transmitted to humans from animals) with symptoms very similar to those seen in the past in smallpox patients, although it is clinically less severe. With the eradication of smallpox in 1980 and subsequent cessation of smallpox vaccination, monkeypox has emerged as the most important orthopoxvirus for public health. Monkeypox primarily occurs in Central and West Africa, often in proximity to tropical rainforests and has been increasingly appearing in urban areas. Animal hosts include a range of rodents and non-human primates.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Monkeypox Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Monkeypox Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Monkeypox Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Monkeypox Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Monkeypox Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Monkeypox Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Monkeypox Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bavarian Nordic inks, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Monkeypox Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- DNA
- Non-replicating Viral Vector
- Protein Subunit
- RNA
- Others
- Aldult
- Child
- Bavarian Nordic inks
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Monkeypox Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Monkeypox Vaccine, with price, sales quantity, revenue, and global market share of Monkeypox Vaccine from 2020 to 2025.
Chapter 3, the Monkeypox Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Monkeypox Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Monkeypox Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Monkeypox Vaccine.
Chapter 14 and 15, to describe Monkeypox Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Monkeypox Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 DNA
1.3.3 Non-replicating Viral Vector
1.3.4 Protein Subunit
1.3.5 RNA
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Monkeypox Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Aldult
1.4.3 Child
1.5 Global Monkeypox Vaccine Market Size & Forecast
1.5.1 Global Monkeypox Vaccine Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Monkeypox Vaccine Sales Quantity (2020-2031)
1.5.3 Global Monkeypox Vaccine Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Bavarian Nordic inks
2.1.1 Bavarian Nordic inks Details
2.1.2 Bavarian Nordic inks Major Business
2.1.3 Bavarian Nordic inks Monkeypox Vaccine Product and Services
2.1.4 Bavarian Nordic inks Monkeypox Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Bavarian Nordic inks Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MONKEYPOX VACCINE BY MANUFACTURER
3.1 Global Monkeypox Vaccine Sales Quantity by Manufacturer (2020-2025)
3.2 Global Monkeypox Vaccine Revenue by Manufacturer (2020-2025)
3.3 Global Monkeypox Vaccine Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Monkeypox Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Monkeypox Vaccine Manufacturer Market Share in 2024
3.4.3 Top 6 Monkeypox Vaccine Manufacturer Market Share in 2024
3.5 Monkeypox Vaccine Market: Overall Company Footprint Analysis
3.5.1 Monkeypox Vaccine Market: Region Footprint
3.5.2 Monkeypox Vaccine Market: Company Product Type Footprint
3.5.3 Monkeypox Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Monkeypox Vaccine Market Size by Region
4.1.1 Global Monkeypox Vaccine Sales Quantity by Region (2020-2031)
4.1.2 Global Monkeypox Vaccine Consumption Value by Region (2020-2031)
4.1.3 Global Monkeypox Vaccine Average Price by Region (2020-2031)
4.2 North America Monkeypox Vaccine Consumption Value (2020-2031)
4.3 Europe Monkeypox Vaccine Consumption Value (2020-2031)
4.4 Asia-Pacific Monkeypox Vaccine Consumption Value (2020-2031)
4.5 South America Monkeypox Vaccine Consumption Value (2020-2031)
4.6 Middle East & Africa Monkeypox Vaccine Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Monkeypox Vaccine Sales Quantity by Type (2020-2031)
5.2 Global Monkeypox Vaccine Consumption Value by Type (2020-2031)
5.3 Global Monkeypox Vaccine Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Monkeypox Vaccine Sales Quantity by Application (2020-2031)
6.2 Global Monkeypox Vaccine Consumption Value by Application (2020-2031)
6.3 Global Monkeypox Vaccine Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Monkeypox Vaccine Sales Quantity by Type (2020-2031)
7.2 North America Monkeypox Vaccine Sales Quantity by Application (2020-2031)
7.3 North America Monkeypox Vaccine Market Size by Country
7.3.1 North America Monkeypox Vaccine Sales Quantity by Country (2020-2031)
7.3.2 North America Monkeypox Vaccine Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Monkeypox Vaccine Sales Quantity by Type (2020-2031)
8.2 Europe Monkeypox Vaccine Sales Quantity by Application (2020-2031)
8.3 Europe Monkeypox Vaccine Market Size by Country
8.3.1 Europe Monkeypox Vaccine Sales Quantity by Country (2020-2031)
8.3.2 Europe Monkeypox Vaccine Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Monkeypox Vaccine Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Monkeypox Vaccine Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Monkeypox Vaccine Market Size by Region
9.3.1 Asia-Pacific Monkeypox Vaccine Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Monkeypox Vaccine Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Monkeypox Vaccine Sales Quantity by Type (2020-2031)
10.2 South America Monkeypox Vaccine Sales Quantity by Application (2020-2031)
10.3 South America Monkeypox Vaccine Market Size by Country
10.3.1 South America Monkeypox Vaccine Sales Quantity by Country (2020-2031)
10.3.2 South America Monkeypox Vaccine Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Monkeypox Vaccine Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Monkeypox Vaccine Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Monkeypox Vaccine Market Size by Country
11.3.1 Middle East & Africa Monkeypox Vaccine Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Monkeypox Vaccine Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Monkeypox Vaccine Market Drivers
12.2 Monkeypox Vaccine Market Restraints
12.3 Monkeypox Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Monkeypox Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Monkeypox Vaccine
13.3 Monkeypox Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Monkeypox Vaccine Typical Distributors
14.3 Monkeypox Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Monkeypox Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 DNA
1.3.3 Non-replicating Viral Vector
1.3.4 Protein Subunit
1.3.5 RNA
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Monkeypox Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Aldult
1.4.3 Child
1.5 Global Monkeypox Vaccine Market Size & Forecast
1.5.1 Global Monkeypox Vaccine Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Monkeypox Vaccine Sales Quantity (2020-2031)
1.5.3 Global Monkeypox Vaccine Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Bavarian Nordic inks
2.1.1 Bavarian Nordic inks Details
2.1.2 Bavarian Nordic inks Major Business
2.1.3 Bavarian Nordic inks Monkeypox Vaccine Product and Services
2.1.4 Bavarian Nordic inks Monkeypox Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Bavarian Nordic inks Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MONKEYPOX VACCINE BY MANUFACTURER
3.1 Global Monkeypox Vaccine Sales Quantity by Manufacturer (2020-2025)
3.2 Global Monkeypox Vaccine Revenue by Manufacturer (2020-2025)
3.3 Global Monkeypox Vaccine Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Monkeypox Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Monkeypox Vaccine Manufacturer Market Share in 2024
3.4.3 Top 6 Monkeypox Vaccine Manufacturer Market Share in 2024
3.5 Monkeypox Vaccine Market: Overall Company Footprint Analysis
3.5.1 Monkeypox Vaccine Market: Region Footprint
3.5.2 Monkeypox Vaccine Market: Company Product Type Footprint
3.5.3 Monkeypox Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Monkeypox Vaccine Market Size by Region
4.1.1 Global Monkeypox Vaccine Sales Quantity by Region (2020-2031)
4.1.2 Global Monkeypox Vaccine Consumption Value by Region (2020-2031)
4.1.3 Global Monkeypox Vaccine Average Price by Region (2020-2031)
4.2 North America Monkeypox Vaccine Consumption Value (2020-2031)
4.3 Europe Monkeypox Vaccine Consumption Value (2020-2031)
4.4 Asia-Pacific Monkeypox Vaccine Consumption Value (2020-2031)
4.5 South America Monkeypox Vaccine Consumption Value (2020-2031)
4.6 Middle East & Africa Monkeypox Vaccine Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Monkeypox Vaccine Sales Quantity by Type (2020-2031)
5.2 Global Monkeypox Vaccine Consumption Value by Type (2020-2031)
5.3 Global Monkeypox Vaccine Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Monkeypox Vaccine Sales Quantity by Application (2020-2031)
6.2 Global Monkeypox Vaccine Consumption Value by Application (2020-2031)
6.3 Global Monkeypox Vaccine Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Monkeypox Vaccine Sales Quantity by Type (2020-2031)
7.2 North America Monkeypox Vaccine Sales Quantity by Application (2020-2031)
7.3 North America Monkeypox Vaccine Market Size by Country
7.3.1 North America Monkeypox Vaccine Sales Quantity by Country (2020-2031)
7.3.2 North America Monkeypox Vaccine Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Monkeypox Vaccine Sales Quantity by Type (2020-2031)
8.2 Europe Monkeypox Vaccine Sales Quantity by Application (2020-2031)
8.3 Europe Monkeypox Vaccine Market Size by Country
8.3.1 Europe Monkeypox Vaccine Sales Quantity by Country (2020-2031)
8.3.2 Europe Monkeypox Vaccine Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Monkeypox Vaccine Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Monkeypox Vaccine Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Monkeypox Vaccine Market Size by Region
9.3.1 Asia-Pacific Monkeypox Vaccine Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Monkeypox Vaccine Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Monkeypox Vaccine Sales Quantity by Type (2020-2031)
10.2 South America Monkeypox Vaccine Sales Quantity by Application (2020-2031)
10.3 South America Monkeypox Vaccine Market Size by Country
10.3.1 South America Monkeypox Vaccine Sales Quantity by Country (2020-2031)
10.3.2 South America Monkeypox Vaccine Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Monkeypox Vaccine Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Monkeypox Vaccine Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Monkeypox Vaccine Market Size by Country
11.3.1 Middle East & Africa Monkeypox Vaccine Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Monkeypox Vaccine Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Monkeypox Vaccine Market Drivers
12.2 Monkeypox Vaccine Market Restraints
12.3 Monkeypox Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Monkeypox Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Monkeypox Vaccine
13.3 Monkeypox Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Monkeypox Vaccine Typical Distributors
14.3 Monkeypox Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Monkeypox Vaccine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Monkeypox Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Bavarian Nordic inks Basic Information, Manufacturing Base and Competitors
Table 4. Bavarian Nordic inks Major Business
Table 5. Bavarian Nordic inks Monkeypox Vaccine Product and Services
Table 6. Bavarian Nordic inks Monkeypox Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Bavarian Nordic inks Recent Developments/Updates
Table 8. Global Monkeypox Vaccine Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 9. Global Monkeypox Vaccine Revenue by Manufacturer (2020-2025) & (USD Million)
Table 10. Global Monkeypox Vaccine Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 11. Market Position of Manufacturers in Monkeypox Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 12. Head Office and Monkeypox Vaccine Production Site of Key Manufacturer
Table 13. Monkeypox Vaccine Market: Company Product Type Footprint
Table 14. Monkeypox Vaccine Market: Company Product Application Footprint
Table 15. Monkeypox Vaccine New Market Entrants and Barriers to Market Entry
Table 16. Monkeypox Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 17. Global Monkeypox Vaccine Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 18. Global Monkeypox Vaccine Sales Quantity by Region (2020-2025) & (K Units)
Table 19. Global Monkeypox Vaccine Sales Quantity by Region (2026-2031) & (K Units)
Table 20. Global Monkeypox Vaccine Consumption Value by Region (2020-2025) & (USD Million)
Table 21. Global Monkeypox Vaccine Consumption Value by Region (2026-2031) & (USD Million)
Table 22. Global Monkeypox Vaccine Average Price by Region (2020-2025) & (US$/Unit)
Table 23. Global Monkeypox Vaccine Average Price by Region (2026-2031) & (US$/Unit)
Table 24. Global Monkeypox Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 25. Global Monkeypox Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 26. Global Monkeypox Vaccine Consumption Value by Type (2020-2025) & (USD Million)
Table 27. Global Monkeypox Vaccine Consumption Value by Type (2026-2031) & (USD Million)
Table 28. Global Monkeypox Vaccine Average Price by Type (2020-2025) & (US$/Unit)
Table 29. Global Monkeypox Vaccine Average Price by Type (2026-2031) & (US$/Unit)
Table 30. Global Monkeypox Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 31. Global Monkeypox Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 32. Global Monkeypox Vaccine Consumption Value by Application (2020-2025) & (USD Million)
Table 33. Global Monkeypox Vaccine Consumption Value by Application (2026-2031) & (USD Million)
Table 34. Global Monkeypox Vaccine Average Price by Application (2020-2025) & (US$/Unit)
Table 35. Global Monkeypox Vaccine Average Price by Application (2026-2031) & (US$/Unit)
Table 36. North America Monkeypox Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 37. North America Monkeypox Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 38. North America Monkeypox Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 39. North America Monkeypox Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 40. North America Monkeypox Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 41. North America Monkeypox Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 42. North America Monkeypox Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 43. North America Monkeypox Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 44. Europe Monkeypox Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 45. Europe Monkeypox Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 46. Europe Monkeypox Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 47. Europe Monkeypox Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 48. Europe Monkeypox Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 49. Europe Monkeypox Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 50. Europe Monkeypox Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 51. Europe Monkeypox Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 52. Asia-Pacific Monkeypox Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 53. Asia-Pacific Monkeypox Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 54. Asia-Pacific Monkeypox Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 55. Asia-Pacific Monkeypox Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 56. Asia-Pacific Monkeypox Vaccine Sales Quantity by Region (2020-2025) & (K Units)
Table 57. Asia-Pacific Monkeypox Vaccine Sales Quantity by Region (2026-2031) & (K Units)
Table 58. Asia-Pacific Monkeypox Vaccine Consumption Value by Region (2020-2025) & (USD Million)
Table 59. Asia-Pacific Monkeypox Vaccine Consumption Value by Region (2026-2031) & (USD Million)
Table 60. South America Monkeypox Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 61. South America Monkeypox Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 62. South America Monkeypox Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 63. South America Monkeypox Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 64. South America Monkeypox Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 65. South America Monkeypox Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 66. South America Monkeypox Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 67. South America Monkeypox Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 68. Middle East & Africa Monkeypox Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 69. Middle East & Africa Monkeypox Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 70. Middle East & Africa Monkeypox Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 71. Middle East & Africa Monkeypox Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 72. Middle East & Africa Monkeypox Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 73. Middle East & Africa Monkeypox Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 74. Middle East & Africa Monkeypox Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 75. Middle East & Africa Monkeypox Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 76. Monkeypox Vaccine Raw Material
Table 77. Key Manufacturers of Monkeypox Vaccine Raw Materials
Table 78. Monkeypox Vaccine Typical Distributors
Table 79. Monkeypox Vaccine Typical Customers
Table 1. Global Monkeypox Vaccine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Monkeypox Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Bavarian Nordic inks Basic Information, Manufacturing Base and Competitors
Table 4. Bavarian Nordic inks Major Business
Table 5. Bavarian Nordic inks Monkeypox Vaccine Product and Services
Table 6. Bavarian Nordic inks Monkeypox Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Bavarian Nordic inks Recent Developments/Updates
Table 8. Global Monkeypox Vaccine Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 9. Global Monkeypox Vaccine Revenue by Manufacturer (2020-2025) & (USD Million)
Table 10. Global Monkeypox Vaccine Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 11. Market Position of Manufacturers in Monkeypox Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 12. Head Office and Monkeypox Vaccine Production Site of Key Manufacturer
Table 13. Monkeypox Vaccine Market: Company Product Type Footprint
Table 14. Monkeypox Vaccine Market: Company Product Application Footprint
Table 15. Monkeypox Vaccine New Market Entrants and Barriers to Market Entry
Table 16. Monkeypox Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 17. Global Monkeypox Vaccine Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 18. Global Monkeypox Vaccine Sales Quantity by Region (2020-2025) & (K Units)
Table 19. Global Monkeypox Vaccine Sales Quantity by Region (2026-2031) & (K Units)
Table 20. Global Monkeypox Vaccine Consumption Value by Region (2020-2025) & (USD Million)
Table 21. Global Monkeypox Vaccine Consumption Value by Region (2026-2031) & (USD Million)
Table 22. Global Monkeypox Vaccine Average Price by Region (2020-2025) & (US$/Unit)
Table 23. Global Monkeypox Vaccine Average Price by Region (2026-2031) & (US$/Unit)
Table 24. Global Monkeypox Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 25. Global Monkeypox Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 26. Global Monkeypox Vaccine Consumption Value by Type (2020-2025) & (USD Million)
Table 27. Global Monkeypox Vaccine Consumption Value by Type (2026-2031) & (USD Million)
Table 28. Global Monkeypox Vaccine Average Price by Type (2020-2025) & (US$/Unit)
Table 29. Global Monkeypox Vaccine Average Price by Type (2026-2031) & (US$/Unit)
Table 30. Global Monkeypox Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 31. Global Monkeypox Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 32. Global Monkeypox Vaccine Consumption Value by Application (2020-2025) & (USD Million)
Table 33. Global Monkeypox Vaccine Consumption Value by Application (2026-2031) & (USD Million)
Table 34. Global Monkeypox Vaccine Average Price by Application (2020-2025) & (US$/Unit)
Table 35. Global Monkeypox Vaccine Average Price by Application (2026-2031) & (US$/Unit)
Table 36. North America Monkeypox Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 37. North America Monkeypox Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 38. North America Monkeypox Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 39. North America Monkeypox Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 40. North America Monkeypox Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 41. North America Monkeypox Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 42. North America Monkeypox Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 43. North America Monkeypox Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 44. Europe Monkeypox Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 45. Europe Monkeypox Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 46. Europe Monkeypox Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 47. Europe Monkeypox Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 48. Europe Monkeypox Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 49. Europe Monkeypox Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 50. Europe Monkeypox Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 51. Europe Monkeypox Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 52. Asia-Pacific Monkeypox Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 53. Asia-Pacific Monkeypox Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 54. Asia-Pacific Monkeypox Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 55. Asia-Pacific Monkeypox Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 56. Asia-Pacific Monkeypox Vaccine Sales Quantity by Region (2020-2025) & (K Units)
Table 57. Asia-Pacific Monkeypox Vaccine Sales Quantity by Region (2026-2031) & (K Units)
Table 58. Asia-Pacific Monkeypox Vaccine Consumption Value by Region (2020-2025) & (USD Million)
Table 59. Asia-Pacific Monkeypox Vaccine Consumption Value by Region (2026-2031) & (USD Million)
Table 60. South America Monkeypox Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 61. South America Monkeypox Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 62. South America Monkeypox Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 63. South America Monkeypox Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 64. South America Monkeypox Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 65. South America Monkeypox Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 66. South America Monkeypox Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 67. South America Monkeypox Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 68. Middle East & Africa Monkeypox Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 69. Middle East & Africa Monkeypox Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 70. Middle East & Africa Monkeypox Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 71. Middle East & Africa Monkeypox Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 72. Middle East & Africa Monkeypox Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 73. Middle East & Africa Monkeypox Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 74. Middle East & Africa Monkeypox Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 75. Middle East & Africa Monkeypox Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 76. Monkeypox Vaccine Raw Material
Table 77. Key Manufacturers of Monkeypox Vaccine Raw Materials
Table 78. Monkeypox Vaccine Typical Distributors
Table 79. Monkeypox Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Monkeypox Vaccine Picture
Figure 2. Global Monkeypox Vaccine Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Monkeypox Vaccine Revenue Market Share by Type in 2024
Figure 4. DNA Examples
Figure 5. Non-replicating Viral Vector Examples
Figure 6. Protein Subunit Examples
Figure 7. RNA Examples
Figure 8. Others Examples
Figure 9. Global Monkeypox Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 10. Global Monkeypox Vaccine Revenue Market Share by Application in 2024
Figure 11. Aldult Examples
Figure 12. Child Examples
Figure 13. Global Monkeypox Vaccine Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Monkeypox Vaccine Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Monkeypox Vaccine Sales Quantity (2020-2031) & (K Units)
Figure 16. Global Monkeypox Vaccine Price (2020-2031) & (US$/Unit)
Figure 17. Global Monkeypox Vaccine Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global Monkeypox Vaccine Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of Monkeypox Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 Monkeypox Vaccine Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 Monkeypox Vaccine Manufacturer (Revenue) Market Share in 2024
Figure 22. Global Monkeypox Vaccine Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global Monkeypox Vaccine Consumption Value Market Share by Region (2020-2031)
Figure 24. North America Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 27. South America Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 29. Global Monkeypox Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global Monkeypox Vaccine Consumption Value Market Share by Type (2020-2031)
Figure 31. Global Monkeypox Vaccine Average Price by Type (2020-2031) & (US$/Unit)
Figure 32. Global Monkeypox Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global Monkeypox Vaccine Revenue Market Share by Application (2020-2031)
Figure 34. Global Monkeypox Vaccine Average Price by Application (2020-2031) & (US$/Unit)
Figure 35. North America Monkeypox Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America Monkeypox Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America Monkeypox Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America Monkeypox Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 39. United States Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe Monkeypox Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe Monkeypox Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe Monkeypox Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe Monkeypox Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 47. France Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific Monkeypox Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific Monkeypox Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific Monkeypox Vaccine Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Monkeypox Vaccine Consumption Value Market Share by Region (2020-2031)
Figure 55. China Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 58. India Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 61. South America Monkeypox Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America Monkeypox Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America Monkeypox Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America Monkeypox Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa Monkeypox Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa Monkeypox Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa Monkeypox Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa Monkeypox Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 75. Monkeypox Vaccine Market Drivers
Figure 76. Monkeypox Vaccine Market Restraints
Figure 77. Monkeypox Vaccine Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Monkeypox Vaccine in 2024
Figure 80. Manufacturing Process Analysis of Monkeypox Vaccine
Figure 81. Monkeypox Vaccine Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Monkeypox Vaccine Picture
Figure 2. Global Monkeypox Vaccine Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Monkeypox Vaccine Revenue Market Share by Type in 2024
Figure 4. DNA Examples
Figure 5. Non-replicating Viral Vector Examples
Figure 6. Protein Subunit Examples
Figure 7. RNA Examples
Figure 8. Others Examples
Figure 9. Global Monkeypox Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 10. Global Monkeypox Vaccine Revenue Market Share by Application in 2024
Figure 11. Aldult Examples
Figure 12. Child Examples
Figure 13. Global Monkeypox Vaccine Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Monkeypox Vaccine Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Monkeypox Vaccine Sales Quantity (2020-2031) & (K Units)
Figure 16. Global Monkeypox Vaccine Price (2020-2031) & (US$/Unit)
Figure 17. Global Monkeypox Vaccine Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global Monkeypox Vaccine Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of Monkeypox Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 Monkeypox Vaccine Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 Monkeypox Vaccine Manufacturer (Revenue) Market Share in 2024
Figure 22. Global Monkeypox Vaccine Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global Monkeypox Vaccine Consumption Value Market Share by Region (2020-2031)
Figure 24. North America Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 27. South America Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 29. Global Monkeypox Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global Monkeypox Vaccine Consumption Value Market Share by Type (2020-2031)
Figure 31. Global Monkeypox Vaccine Average Price by Type (2020-2031) & (US$/Unit)
Figure 32. Global Monkeypox Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global Monkeypox Vaccine Revenue Market Share by Application (2020-2031)
Figure 34. Global Monkeypox Vaccine Average Price by Application (2020-2031) & (US$/Unit)
Figure 35. North America Monkeypox Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America Monkeypox Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America Monkeypox Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America Monkeypox Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 39. United States Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe Monkeypox Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe Monkeypox Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe Monkeypox Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe Monkeypox Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 47. France Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific Monkeypox Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific Monkeypox Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific Monkeypox Vaccine Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Monkeypox Vaccine Consumption Value Market Share by Region (2020-2031)
Figure 55. China Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 58. India Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 61. South America Monkeypox Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America Monkeypox Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America Monkeypox Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America Monkeypox Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa Monkeypox Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa Monkeypox Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa Monkeypox Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa Monkeypox Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa Monkeypox Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 75. Monkeypox Vaccine Market Drivers
Figure 76. Monkeypox Vaccine Market Restraints
Figure 77. Monkeypox Vaccine Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Monkeypox Vaccine in 2024
Figure 80. Manufacturing Process Analysis of Monkeypox Vaccine
Figure 81. Monkeypox Vaccine Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
